Repligen Profit Margin

The latest profit margin for RGEN is 5.29% as of June 2026. That compares with 0.74% in the prior-year period — up 613.3% year over year. That is below the Healthcare sector average of 15.29%. Investors often review this figure alongside Repligen's historical trend and sector peers before judging valuation or financial health.

Over the past year, RGEN's profit margin moved from 0.74% to 5.29% — a 613.3% year-over-year increase. If the trend continues in the same direction for several quarters, it can signal a meaningful shift in Repligen's valuation or profitability profile.

Against Healthcare companies, RGEN currently prints 5.29% for profit margin, while the sector average sits near 15.29%. That is roughly 65.4% below the sector mean. Large gaps often invite a closer look at Repligen's growth, margins, and balance sheet.

Profit Margin shows how effectively Repligen converts resources into returns. At 5.29%, RGEN may look efficient or underperforming depending on peer benchmarks and trend direction. That compares with 0.74% in the prior-year period — up 613.3% year over year. Pair the percentage with revenue growth and leverage for a fuller health check.

After noting RGEN's profit margin (5.29%), review year-over-year change from 0.74%, peer averages, and a few neighboring metrics such as revenue, margins, or valuation multiples. That combination usually beats staring at a single figure. The navigation links on this page jump you to those related views.